Free Trial

Newmont (NEM) Financials

Newmont logo
$70.66 +0.57 (+0.81%)
Closing price 03:59 PM Eastern
Extended Trading
$70.59 -0.07 (-0.10%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Newmont

Annual Income Statements for Newmont

This table shows Newmont's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
508 220 -629 -114 341 2,805 2,829 1,166 -429 -2,494 3,348
Consolidated Net Income / (Loss)
329 304 -943 -109 380 2,884 2,791 233 -369 -2,467 3,381
Net Income / (Loss) Continuing Operations
613 -141 -812 -71 319 2,956 2,628 176 -399 -2,494 3,313
Total Pre-Tax Income
821 295 -220 1,072 738 3,693 3,143 1,108 -51 -2,031 4,577
Total Operating Income
993 457 -16 1,259 790 1,277 2,806 1,257 203 -1,700 4,527
Total Gross Profit
2,900 2,507 2,625 2,946 3,160 4,545 6,483 6,787 5,447 5,113 9,719
Total Revenue
6,819 6,085 6,680 7,379 7,253 9,740 11,497 12,222 11,915 11,812 18,682
Operating Revenue
6,819 6,085 6,680 7,379 7,253 9,740 11,497 12,222 11,915 11,812 18,682
Total Cost of Revenue
3,919 3,578 4,055 4,433 4,093 5,195 5,014 5,435 6,468 6,699 8,963
Operating Cost of Revenue
3,919 3,578 4,055 4,433 4,093 5,195 5,014 5,435 6,468 6,699 8,963
Total Operating Expenses
1,907 2,050 2,641 1,687 2,370 3,268 3,677 5,530 5,244 6,813 5,192
Selling, General & Admin Expense
329 357 233 269 273 613 653 402 358 816 633
Research & Development Expense
159 126 134 143 153 150 122 154 229 200 197
Exploration Expense
163 156 - - 197 265 187 209 231 265 266
Depreciation Expense
1,088 1,102 1,213 1,261 1,215 1,960 2,300 2,323 2,185 2,108 2,576
Other Operating Expenses / (Income)
142 253 - - 163 280 366 2,417 921 1,533 1,442
Impairment Charge
26 56 1,003 14 369 0.00 49 25 1,320 1,891 78
Total Other Income / (Expense), net
-172 -162 -204 -187 -52 2,416 337 -149 -254 -331 50
Interest & Investment Income
-330 -297 -273 -241 -207 2,089 -308 - -227 -243 -375
Other Income / (Expense), net
158 135 69 54 155 327 645 125 -27 -88 425
Income Tax Expense
204 391 579 1,127 386 832 704 1,098 455 526 1,397
Other Gains / (Losses), net
-4.00 -45 -13 -16 -33 95 189 166 107 63 133
Net Income / (Loss) Discontinued Operations
-284 445 -131 -38 61 -72 163 57 30 27 68
Net Income / (Loss) Attributable to Noncontrolling Interest
-179 84 -314 5.00 39 79 -38 -933 60 27 33
Basic Earnings per Share
$1.02 $0.43 ($1.19) ($0.21) $0.64 $3.82 $3.52 $1.46 ($0.54) ($2.97) $2.92
Weighted Average Basic Shares Outstanding
499M 516M 530M 533.47M 532.67M 735M 804M 799M 794M 841M 1.15B
Diluted Earnings per Share
$1.02 $0.43 ($1.18) ($0.21) $0.64 $3.81 $3.51 $1.46 ($0.54) ($2.97) $2.92
Weighted Average Diluted Shares Outstanding
499M 516M 530M 533.47M 532.67M 737M 806M 801M 795M 841M 1.15B
Weighted Average Basic & Diluted Shares Outstanding
499M 516M 530M 533.47M 532.67M 807.58M 800.31M 792.50M 793.79M 1.15B 1.13B
Cash Dividends to Common per Share
$0.23 $0.10 $0.13 $0.25 $0.56 $1.44 $1.04 $2.20 $2.20 $1.60 $1.00

Quarterly Income Statements for Newmont

This table shows Newmont's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
-1,477 351 155 158 -3,158 170 853 922 1,403 1,891 2,061
Consolidated Net Income / (Loss)
-1,458 363 155 163 -3,148 179 857 924 1,421 1,902 2,075
Net Income / (Loss) Continuing Operations
-1,469 351 153 162 -3,160 175 842 875 1,421 1,902 2,075
Total Pre-Tax Income
-1,383 539 300 232 -3,102 428 1,036 1,059 2,054 2,471 3,118
Total Operating Income
-1,431 505 366 238 -2,809 400 1,039 1,128 1,960 2,249 3,068
Total Gross Profit
1,420 1,197 1,140 1,122 1,654 1,917 2,246 2,295 3,261 2,904 3,316
Total Revenue
3,200 2,679 2,683 2,493 3,957 4,023 4,402 4,605 5,652 5,010 5,317
Operating Revenue
3,200 2,679 2,683 2,493 3,957 4,023 4,402 4,605 5,652 5,010 5,317
Total Cost of Revenue
1,780 1,482 1,543 1,371 2,303 2,106 2,156 2,310 2,391 2,106 2,001
Operating Cost of Revenue
1,780 1,482 1,543 1,371 2,303 2,106 2,156 2,310 2,391 2,106 2,001
Total Operating Expenses
2,851 692 774 884 4,463 1,517 1,207 1,167 1,301 655 248
Selling, General & Admin Expense
115 82 112 107 515 174 159 168 132 153 143
Research & Development Expense
60 35 44 53 68 53 49 47 48 43 40
Exploration Expense
62 48 66 78 73 53 57 74 82 49 61
Depreciation Expense
571 461 486 480 681 654 602 631 689 593 620
Other Operating Expenses / (Income)
758 66 66 166 1,235 98 340 247 272 93 -616
Total Other Income / (Expense), net
48 34 -66 -6.00 -293 28 -3.00 -69 94 222 50
Interest & Investment Income
- -65 -49 -48 -81 -93 -103 -86 -93 -79 -65
Other Income / (Expense), net
101 99 -17 42 -212 121 100 17 187 301 115
Income Tax Expense
112 213 163 73 77 260 191 244 702 647 1,092
Other Gains / (Losses), net
26 25 16 3.00 19 7.00 -3.00 60 69 78 49
Net Income / (Loss) Discontinued Operations
11 12 2.00 1.00 12 4.00 15 49 - 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
19 12 0.00 5.00 10 9.00 4.00 2.00 18 11 14
Basic Earnings per Share
($1.86) $0.44 $0.19 $0.20 ($3.80) $0.15 $0.74 $0.80 $1.23 $1.68 $1.86
Weighted Average Basic Shares Outstanding
794M 794M 795M 795M 841M 1.15B 1.15B 1.15B 1.15B 1.13B 1.11B
Diluted Earnings per Share
($1.86) $0.44 $0.19 $0.20 ($3.80) $0.15 $0.74 $0.80 $1.23 $1.68 $1.85
Weighted Average Diluted Shares Outstanding
795M 795M 795M 796M 841M 1.15B 1.16B 1.15B 1.15B 1.13B 1.11B
Weighted Average Basic & Diluted Shares Outstanding
793.79M 794.71M 794.73M 794.80M 1.15B 1.15B 1.15B 1.14B 1.13B 1.11B 1.10B
Cash Dividends to Common per Share
- $0.40 $0.40 $0.40 - $0.25 $0.25 $0.25 - $0.25 $0.25

Annual Cash Flow Statements for Newmont

This table details how cash moves in and out of Newmont's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
849 382 897 510 195 -1,140 3,299 -555 -2,149 156 550
Net Cash From Operating Activities
1,438 2,145 2,786 2,124 1,827 2,866 4,882 4,279 3,220 2,763 6,363
Net Cash From Continuing Operating Activities
1,423 1,588 1,917 2,139 1,837 2,876 4,890 4,266 3,198 2,754 6,318
Net Income / (Loss) Continuing Operations
613 -141 -812 -71 319 2,956 2,628 176 -399 -2,494 3,313
Consolidated Net Income / (Loss)
329 304 -943 -109 380 2,884 2,791 233 -369 -2,467 3,381
Net Income / (Loss) Discontinued Operations
-284 445 -131 -38 61 -72 163 57 30 27 68
Depreciation Expense
1,088 1,102 1,213 1,261 1,215 1,960 2,300 2,323 2,185 2,108 2,576
Non-Cash Adjustments To Reconcile Net Income
489 635 1,559 544 896 -2,065 -111 2,417 2,531 3,757 1,374
Changes in Operating Assets and Liabilities, net
-767 -8.00 -43 405 -593 25 73 -650 -1,119 -617 -945
Net Cash From Discontinued Operating Activities
15 557 869 -15 -10 -10 -8.00 13 22 9.00 45
Net Cash From Investing Activities
-507 -2,041 -74 -946 -1,177 -1,226 91 -1,868 -2,983 -1,002 -2,702
Net Cash From Continuing Investing Activities
-437 -1,951 -28 -946 -1,177 -1,226 166 -1,868 -2,983 -1,002 -2,855
Purchase of Property, Plant & Equipment
-1,040 -1,311 -1,133 -866 -1,032 -1,463 -1,302 -1,653 -2,131 -2,666 -3,402
Acquisitions
-28 -823 0.00 - -140 99 -60 -478 -209 560 -96
Purchase of Investments
-26 -17 -15 -130 -39 -112 -37 -59 -940 -551 -66
Sale of Property, Plant & Equipment
661 203 9.00 5.00 24 30 1,156 84 16 0.00 560
Sale and/or Maturity of Investments
25 29 195 35 18 199 365 212 326 1,633 105
Other Investing Activities, net
-29 -32 -4.00 10 -8.00 21 44 26 -45 22 44
Net Cash From Discontinued Investing Activities
-70 -90 -46 - 0.00 0.00 -75 - 0.00 0.00 153
Net Cash From Financing Activities
-65 302 -1,817 -668 -455 -2,777 -1,680 -2,958 -2,356 -1,603 -2,953
Net Cash From Continuing Financing Activities
-37 527 -1,486 -668 -455 -2,777 -1,680 -2,958 -2,356 -1,603 -2,953
Repayment of Debt
-688 -231 -1,312 -388 0.00 -1,901 -1,111 -1,437 -83 -84 -3,891
Repurchase of Common Equity
- - 0.00 - -98 -479 -521 -525 0.00 0.00 -1,246
Payment of Dividends
-127 -63 -235 -360 -461 -1,075 -1,031 -1,957 -1,937 -1,565 -1,306
Issuance of Debt
599 - - - 0.00 690 985 992 0.00 0.00 3,476
Issuance of Common Equity
179 821 66 94 148 93 112 100 117 138 115
Other Financing Activities, net
0.00 0.00 -5.00 -14 -44 -105 -114 -131 -453 -92 -101
Other Net Changes in Cash
- -24 2.00 - - - - - - - -138
Cash Interest Paid
- - - - - 273 261 229 172 228 317
Cash Income Taxes Paid
- - - - - 437 400 1,534 1,122 794 966

Quarterly Cash Flow Statements for Newmont

This table details how cash moves in and out of Newmont's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
-196 -219 175 364 -164 -719 118 156 600 1,080 1,488
Net Cash From Operating Activities
1,010 481 663 1,003 616 776 1,428 1,648 2,511 2,031 2,384
Net Cash From Continuing Operating Activities
1,010 481 656 1,001 616 776 1,394 1,637 2,511 2,031 2,384
Net Income / (Loss) Continuing Operations
-1,469 351 153 162 -3,160 175 842 875 1,421 1,902 2,075
Consolidated Net Income / (Loss)
-1,458 363 155 163 -3,148 179 857 924 1,421 1,902 2,075
Depreciation Expense
571 461 486 480 681 654 602 631 689 593 620
Non-Cash Adjustments To Reconcile Net Income
2,070 16 118 256 3,367 560 308 333 173 -448 -684
Changes in Operating Assets and Liabilities, net
-162 -347 -101 103 -272 -613 -358 -202 228 -16 373
Net Cash From Investing Activities
-726 -342 -158 -253 -249 -798 -641 -562 -701 738 679
Net Cash From Continuing Investing Activities
-726 -342 -158 -253 -249 -798 -641 -715 -701 738 679
Purchase of Property, Plant & Equipment
-646 -526 -616 -604 -920 -850 -800 -877 -875 -826 -674
Acquisitions
-57 -41 -23 -26 650 -15 -5.00 -15 -61 -31 -17
Sale of Property, Plant & Equipment
- - - - - 0.00 - - - 1,684 991
Sale and/or Maturity of Investments
217 738 487 379 29 28 233 135 -323 27 391
Other Investing Activities, net
19 12 11 1.00 -2.00 39 14 -2.00 2.00 -116 1.00
Net Cash From Financing Activities
-479 -350 -334 -381 -538 -299 -658 -789 -1,207 -1,662 -1,745
Net Cash From Continuing Financing Activities
-479 -350 -334 -381 -538 -299 -658 -789 -1,207 -1,662 -1,745
Repayment of Debt
-3.00 -1.00 -2.00 -36 -45 -3,440 -238 -133 -80 -989 -406
Repurchase of Common Equity
- - - - - 0.00 - -344 -798 -348 -1,011
Payment of Dividends
-487 -352 -350 -359 -504 -329 -325 -322 -330 -326 -335
Issuance of Common Equity
28 41 34 32 31 22 31 34 28 39 31
Other Financing Activities, net
-17 -38 -16 -18 -20 -28 -22 -24 -27 -38 -24
Other Net Changes in Cash
- -8.00 - - - -395 - - 2.00 -22 160

Annual Balance Sheets for Newmont

This table presents Newmont's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
24,916 25,130 21,031 20,646 20,715 39,974 41,369 40,564 38,482 55,506 56,349
Total Current Assets
5,439 4,983 4,677 5,066 5,277 6,272 8,505 7,696 6,515 7,512 12,275
Cash & Equivalents
2,403 2,363 2,756 3,259 3,397 2,243 5,540 4,992 2,877 3,002 3,619
Short-Term Investments
73 19 56 62 48 237 290 82 880 23 21
Accounts Receivable
476 215 343 237 254 373 449 337 690 734 1,056
Inventories, net
1,366 1,343 1,380 1,355 1,327 1,826 1,790 1,787 1,753 2,642 2,184
Other Current Assets
881 83 142 153 251 570 436 498 303 1,111 786
Other Current Nonoperating Assets
- 960 - - - 1,023 - - - 0.00 4,609
Plant, Property, & Equipment, net
13,650 13,210 12,485 12,338 12,258 0.00 0.00 0.00 0.00 0.00 33,547
Total Noncurrent Assets
5,827 6,937 3,869 3,242 3,180 33,702 32,864 32,868 31,771 47,994 10,527
Long-Term Investments
334 402 207 280 271 3,199 3,197 3,243 3,278 4,143 4,471
Goodwill
- - - - 58 2,674 2,771 2,771 1,971 3,001 2,658
Noncurrent Deferred & Refundable Income Taxes
1,790 1,712 1,331 549 401 549 337 269 173 268 124
Other Noncurrent Operating Assets
3,703 2,341 2,331 2,413 2,450 27,280 26,559 26,585 26,349 40,582 3,274
Total Liabilities & Shareholders' Equity
24,916 25,130 21,031 20,646 20,715 39,974 41,369 40,564 38,482 55,506 56,349
Total Liabilities
11,827 10,838 9,157 9,127 9,203 17,557 17,490 18,703 18,949 26,301 26,240
Total Current Liabilities
2,198 1,416 1,750 1,398 1,787 2,385 3,369 2,654 2,926 5,998 7,543
Short-Term Debt
166 9.00 566 4.00 653 0.00 551 87 0.00 1,923 924
Accounts Payable
406 315 320 375 303 539 493 518 633 960 843
Current Deferred & Payable Income Tax Liabilities
74 38 153 248 71 162 657 384 199 88 381
Current Employee Benefit Liabilities
307 278 304 309 305 361 380 386 399 551 630
Other Current Liabilities
1,245 487 407 462 455 980 1,288 1,279 1,695 2,476 2,588
Other Current Nonoperating Liabilities
- 289 - - - 343 - - - 0.00 2,177
Total Noncurrent Liabilities
9,629 9,422 7,407 7,729 7,416 15,172 14,121 16,049 16,023 20,303 18,697
Long-Term Debt
6,480 5,854 4,049 4,040 3,418 6,138 5,480 5,565 5,571 6,951 7,552
Capital Lease Obligations
- - - 21 190 596 565 544 465 448 389
Asset Retirement Reserve & Litigation Obligation
1,606 1,555 2,029 2,345 2,481 3,464 3,818 - 6,578 8,167 6,394
Noncurrent Deferred & Payable Income Tax Liabilities
656 538 592 595 612 2,407 2,073 2,144 1,809 2,987 2,820
Noncurrent Employee Benefit Liabilities
492 409 411 386 401 448 493 439 342 655 555
Other Noncurrent Operating Liabilities
395 310 326 342 314 2,119 1,692 7,357 1,258 1,095 987
Commitments & Contingencies
- - - - - - - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
13,089 14,292 11,874 11,519 11,465 22,370 23,845 21,813 19,533 29,205 30,109
Total Preferred & Common Equity
10,274 11,350 10,721 10,535 10,502 21,420 23,008 22,022 19,354 29,027 29,928
Total Common Equity
10,274 11,350 10,721 10,535 10,502 21,420 23,008 22,022 19,354 29,027 29,928
Common Stock
9,510 10,274 10,339 10,447 10,473 19,514 19,390 19,257 18,648 32,273 31,621
Retained Earnings
1,242 1,410 716 410 383 2,291 4,002 3,098 916 -2,996 -1,320
Treasury Stock
- - - -30 -70 -120 -168 -200 -239 -264 -278
Accumulated Other Comprehensive Income / (Loss)
-478 -334 -334 -292 -284 -265 -216 -133 29 14 -95
Noncontrolling Interest
2,815 2,942 1,153 984 963 950 837 -209 179 178 181

Quarterly Balance Sheets for Newmont

This table presents Newmont's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets
38,482 38,374 38,133 38,084 55,506 55,335 55,678 56,175 56,349 55,519 55,165
Total Current Assets
6,515 6,559 6,134 5,955 7,512 11,806 12,070 12,577 12,275 10,740 10,399
Cash & Equivalents
2,877 2,657 2,829 3,190 3,002 2,336 2,602 3,016 3,619 4,698 6,185
Short-Term Investments
880 847 409 24 23 23 50 43 21 18 468
Accounts Receivable
690 348 185 78 734 782 955 974 1,056 887 637
Inventories, net
1,753 1,972 1,969 1,956 2,642 2,130 2,148 2,175 2,184 2,285 2,267
Other Current Assets
303 735 742 707 1,111 879 945 795 786 653 740
Other Current Nonoperating Assets
- - - - 0.00 5,656 5,370 5,574 4,609 2,199 102
Plant, Property, & Equipment, net
0.00 24,097 24,284 24,474 0.00 33,564 33,655 33,697 0.00 33,568 33,591
Total Noncurrent Assets
31,771 7,718 7,715 7,655 47,994 9,553 9,953 9,901 44,074 11,211 11,175
Long-Term Investments
3,278 3,216 3,172 3,133 4,143 4,138 4,141 4,150 4,471 4,856 4,455
Goodwill
1,971 1,971 1,971 1,971 3,001 2,792 2,792 2,721 2,658 2,658 2,658
Noncurrent Deferred & Refundable Income Taxes
173 170 166 138 268 210 273 229 124 59 55
Other Noncurrent Operating Assets
26,349 2,361 2,406 2,413 40,582 2,413 2,747 2,801 36,821 3,638 4,007
Total Liabilities & Shareholders' Equity
38,482 38,374 38,133 38,084 55,506 55,335 55,678 56,175 56,349 55,519 55,165
Total Liabilities
18,949 18,815 18,718 18,824 26,301 26,260 26,115 26,279 26,240 24,088 22,878
Total Current Liabilities
2,926 2,752 2,693 2,808 5,998 5,482 5,732 6,408 7,543 5,426 4,670
Short-Term Debt
0.00 - - - 1,923 0.00 0.00 0.00 924 0.00 0.00
Accounts Payable
633 648 565 651 960 698 683 772 843 771 742
Current Deferred & Payable Income Tax Liabilities
199 213 155 143 88 136 264 317 381 378 705
Current Employee Benefit Liabilities
399 302 313 345 551 414 457 542 630 502 562
Other Current Liabilities
1,695 1,589 1,660 1,669 2,476 1,883 1,923 2,193 2,588 2,466 2,656
Other Current Nonoperating Liabilities
- - - - 0.00 2,351 2,405 2,584 2,177 1,309 5.00
Total Noncurrent Liabilities
16,023 16,063 16,025 16,016 20,303 20,778 20,383 19,871 18,697 18,662 18,208
Long-Term Debt
5,571 5,572 5,574 5,575 6,951 8,933 8,692 8,550 7,552 7,507 7,132
Capital Lease Obligations
465 451 441 418 448 436 - 437 389 370 363
Asset Retirement Reserve & Litigation Obligation
6,578 6,603 6,604 6,714 8,167 6,652 6,620 6,410 6,394 6,376 6,216
Noncurrent Deferred & Payable Income Tax Liabilities
1,809 1,800 1,795 1,696 2,987 3,094 3,046 2,883 2,820 2,733 2,890
Noncurrent Employee Benefit Liabilities
342 395 399 397 655 610 616 632 555 575 596
Other Noncurrent Operating Liabilities
1,258 1,242 1,212 1,216 1,095 1,053 1,409 959 987 1,101 1,011
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
19,533 19,559 19,415 19,260 29,205 29,075 29,563 29,896 30,109 31,431 32,287
Total Preferred & Common Equity
19,354 19,377 19,225 19,074 29,027 28,890 29,379 29,712 29,928 31,248 32,112
Total Common Equity
19,354 19,377 19,225 19,074 29,027 28,890 29,379 29,712 29,928 31,248 32,112
Common Stock
18,648 18,667 18,688 18,706 32,273 32,291 32,245 32,068 31,621 31,427 30,913
Retained Earnings
916 948 785 623 -2,996 -3,111 -2,585 -2,101 -1,320 153 1,449
Treasury Stock
-239 -261 -261 -263 -264 -274 -274 -276 -278 -293 -294
Accumulated Other Comprehensive Income / (Loss)
29 23 13 8.00 14 -16 -7.00 21 -95 -39 44
Noncontrolling Interest
179 182 190 186 178 185 184 184 181 183 175

Annual Metrics And Ratios for Newmont

This table displays calculated financial ratios and metrics derived from Newmont's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-18.96% -10.76% 9.78% 10.46% -1.71% 34.29% 18.04% 6.31% -2.51% -0.86% 58.16%
EBITDA Growth
215.35% -24.34% -25.27% 103.32% -16.08% 65.00% 61.36% -35.58% -36.28% -86.45% 2,252.50%
EBIT Growth
134.85% -48.57% -91.05% 2,377.36% -28.03% 69.74% 115.15% -59.95% -87.26% -1,115.91% 376.96%
NOPAT Growth
129.19% -119.93% 92.47% -476.73% 683.34% 162.55% 120.10% -99.48% 1,152.56% -937.44% 364.31%
Net Income Growth
111.77% -7.60% -410.20% 88.44% 448.62% 658.95% -3.22% -91.65% -258.37% -568.56% 237.05%
EPS Growth
120.04% -57.84% -374.42% 82.20% 404.76% 495.31% -7.87% -58.40% -136.99% -450.00% 198.32%
Operating Cash Flow Growth
-6.80% 49.17% 29.88% -23.76% -13.98% 56.87% 70.34% -12.35% -24.75% -14.19% 130.29%
Free Cash Flow Firm Growth
7,033.99% 28.89% -17.17% -4.72% -78.71% -3,318.50% 136.13% -51.18% -9.49% -1,014.02% 142.70%
Invested Capital Growth
-3.71% -11.53% -10.04% -11.04% 0.62% 89.04% -5.90% -7.96% -7.16% 71.12% -9.34%
Revenue Q/Q Growth
-8.63% -12.87% 19.99% 2.46% 1.58% 10.42% 3.74% 0.07% -1.57% 6.85% 9.98%
EBITDA Q/Q Growth
1,508.18% -38.91% -13.88% 582.76% -32.22% 21.27% 6.07% -27.76% -28.84% -83.17% 220.07%
EBIT Q/Q Growth
178.73% -67.38% -80.22% 248.87% -52.39% 27.71% 10.47% -51.17% -83.47% -1,743.30% 2,392.59%
NOPAT Q/Q Growth
167.77% -115.38% 99.90% 89.63% 186.90% 22.64% -8.84% -99.12% -36.10% -427.95% 1,956.71%
Net Income Q/Q Growth
132.77% -57.95% -98.95% 73.99% 350.00% 23.35% 7.84% -86.77% -213.54% -217.50% 384.60%
EPS Q/Q Growth
173.38% -55.21% -14.56% -240.00% 268.42% 36.56% -0.28% -42.29% -142.52% -188.35% 238.39%
Operating Cash Flow Q/Q Growth
14.04% -11.80% 14.60% 5.88% -0.27% 19.37% 10.93% -8.29% -8.24% -12.48% 42.41%
Free Cash Flow Firm Q/Q Growth
668.70% 63.42% 117.97% 43.68% 96.09% 7.38% -13.00% -31.73% 158.33% -1,202.05% 161.05%
Invested Capital Q/Q Growth
-4.32% -14.69% -7.47% -7.42% -2.42% -3.77% -2.62% -5.11% -10.26% 65.87% -0.88%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
42.53% 41.20% 39.30% 39.92% 43.57% 46.66% 56.39% 55.53% 45.72% 43.29% 52.02%
EBITDA Margin
32.83% 27.84% 18.95% 34.88% 29.78% 36.59% 50.02% 30.31% 19.82% 2.71% 40.30%
Operating Margin
14.56% 7.51% -0.24% 17.06% 10.89% 13.11% 24.41% 10.28% 1.70% -14.39% 24.23%
EBIT Margin
16.88% 9.73% 0.79% 17.79% 13.03% 16.47% 30.02% 11.31% 1.48% -15.14% 26.51%
Profit (Net Income) Margin
4.82% 5.00% -14.12% -1.48% 5.24% 29.61% 24.28% 1.91% -3.10% -20.89% 18.10%
Tax Burden Percent
40.07% 103.05% 428.64% -10.17% 51.49% 78.09% 88.80% 21.03% 723.53% 121.47% 73.87%
Interest Burden Percent
71.33% 49.83% -415.09% 81.65% 78.10% 230.24% 91.08% 80.17% -28.98% 113.59% 92.43%
Effective Tax Rate
24.85% 132.54% 0.00% 105.13% 52.30% 22.53% 22.40% 99.10% 0.00% 0.00% 30.52%
Return on Invested Capital (ROIC)
4.33% -0.93% -0.08% -0.51% 3.13% 5.68% 9.84% 0.06% 0.75% -4.79% 10.52%
ROIC Less NNEP Spread (ROIC-NNEP)
-5.49% 19.11% -81.89% -4.82% 3.77% 417.57% -49.84% -9.68% 31.46% -274.48% 109.57%
Return on Net Nonoperating Assets (RNNOA)
-1.79% 3.15% -7.13% -0.42% 0.17% 11.32% 2.21% 0.96% -2.53% -5.33% 0.88%
Return on Equity (ROE)
2.53% 2.22% -7.21% -0.93% 3.30% 17.00% 12.06% 1.02% -1.78% -10.12% 11.40%
Cash Return on Invested Capital (CROIC)
8.11% 11.30% 10.50% 11.18% 2.52% -55.93% 15.92% 8.35% 8.18% -57.25% 20.32%
Operating Return on Assets (OROA)
4.65% 2.37% 0.23% 6.30% 4.57% 5.29% 8.49% 3.37% 0.45% -3.80% 8.85%
Return on Assets (ROA)
1.33% 1.21% -4.09% -0.52% 1.84% 9.50% 6.86% 0.57% -0.93% -5.25% 6.05%
Return on Common Equity (ROCE)
1.97% 1.75% -6.08% -0.85% 3.01% 15.99% 11.57% 1.00% -1.78% -10.05% 11.33%
Return on Equity Simple (ROE_SIMPLE)
3.20% 2.68% -8.80% -1.03% 3.62% 13.46% 12.13% 1.06% -1.91% -8.50% 11.30%
Net Operating Profit after Tax (NOPAT)
746 -149 -11 -65 377 989 2,177 11 142 -1,190 3,145
NOPAT Margin
10.94% -2.44% -0.17% -0.88% 5.20% 10.16% 18.94% 0.09% 1.19% -10.07% 16.84%
Net Nonoperating Expense Percent (NNEP)
9.81% -20.04% 81.81% 4.31% -0.63% -411.89% 59.68% 9.74% -30.72% 269.69% -99.05%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 0.56% -3.09% 8.07%
Cost of Revenue to Revenue
57.47% 58.80% 60.70% 60.08% 56.43% 53.34% 43.61% 44.47% 54.28% 56.71% 47.98%
SG&A Expenses to Revenue
4.82% 5.87% 3.49% 3.65% 3.76% 6.29% 5.68% 3.29% 3.00% 6.91% 3.39%
R&D to Revenue
2.33% 2.07% 2.01% 1.94% 2.11% 1.54% 1.06% 1.26% 1.92% 1.69% 1.05%
Operating Expenses to Revenue
27.97% 33.69% 39.54% 22.86% 32.68% 33.55% 31.98% 45.25% 44.01% 57.68% 27.79%
Earnings before Interest and Taxes (EBIT)
1,151 592 53 1,313 945 1,604 3,451 1,382 176 -1,788 4,952
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,239 1,694 1,266 2,574 2,160 3,564 5,751 3,705 2,361 320 7,528
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.74 0.68 1.37 1.55 1.46 1.43 1.84 2.04 1.82 1.11 1.42
Price to Tangible Book Value (P/TBV)
0.74 0.68 1.37 1.55 1.46 1.64 2.09 2.34 2.02 1.23 1.55
Price to Revenue (P/Rev)
1.11 1.26 2.19 2.21 2.11 3.15 3.67 3.68 2.95 2.72 2.27
Price to Earnings (P/E)
14.90 34.90 0.00 0.00 44.85 10.95 14.93 38.62 0.00 0.00 12.66
Dividend Yield
1.48% 0.69% 0.45% 0.82% 1.95% 3.84% 1.98% 3.90% 4.97% 5.32% 2.69%
Earnings Yield
6.71% 2.87% 0.00% 0.00% 2.23% 9.13% 6.70% 2.59% 0.00% 0.00% 7.90%
Enterprise Value to Invested Capital (EV/IC)
0.84 0.91 1.29 1.48 1.40 1.44 1.90 2.17 1.87 1.10 1.52
Enterprise Value to Revenue (EV/Rev)
2.09 2.25 2.60 2.41 2.32 3.37 3.54 3.50 2.88 2.91 2.32
Enterprise Value to EBITDA (EV/EBITDA)
6.35 8.09 13.74 6.90 7.80 9.20 7.07 11.54 14.53 107.59 5.75
Enterprise Value to EBIT (EV/EBIT)
12.35 23.14 328.13 13.53 17.83 20.44 11.79 30.93 194.95 0.00 8.75
Enterprise Value to NOPAT (EV/NOPAT)
19.05 0.00 0.00 0.00 44.72 33.13 18.68 3,768.07 241.46 0.00 13.77
Enterprise Value to Operating Cash Flow (EV/OCF)
9.89 6.39 6.24 8.36 9.22 11.44 8.33 9.99 10.66 12.46 6.81
Enterprise Value to Free Cash Flow (EV/FCFF)
10.17 7.60 11.65 12.49 55.65 0.00 11.55 24.86 22.05 0.00 7.13
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.51 0.41 0.39 0.35 0.37 0.30 0.28 0.28 0.31 0.32 0.29
Long-Term Debt to Equity
0.50 0.41 0.34 0.35 0.31 0.30 0.25 0.28 0.31 0.25 0.26
Financial Leverage
0.33 0.17 0.09 0.09 0.04 0.03 -0.04 -0.10 -0.08 0.02 0.01
Leverage Ratio
1.90 1.83 1.76 1.78 1.80 1.79 1.76 1.79 1.91 1.93 1.89
Compound Leverage Factor
1.36 0.91 -7.32 1.45 1.40 4.12 1.60 1.44 -0.55 2.19 1.74
Debt to Total Capital
33.68% 29.09% 27.99% 26.08% 27.01% 23.10% 21.64% 22.08% 23.61% 24.20% 22.75%
Short-Term Debt to Total Capital
0.84% 0.04% 3.43% 0.03% 4.14% 0.00% 1.81% 0.31% 0.00% 4.99% 2.37%
Long-Term Debt to Total Capital
32.84% 29.04% 24.56% 26.06% 22.87% 23.10% 19.84% 21.77% 23.61% 19.20% 20.38%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
14.26% 14.60% 6.99% 6.31% 6.40% 3.42% 2.86% -0.57% 0.70% 0.46% 0.46%
Common Equity to Total Capital
52.06% 56.31% 65.02% 67.60% 66.58% 73.48% 75.50% 78.49% 75.69% 75.34% 76.79%
Debt to EBITDA
2.97 3.46 3.65 1.58 1.97 1.89 1.15 1.67 2.56 29.13 1.18
Net Debt to EBITDA
1.71 1.82 1.26 0.18 0.25 0.30 -0.42 -0.57 -0.42 6.73 0.10
Long-Term Debt to EBITDA
2.89 3.46 3.20 1.58 1.67 1.89 1.05 1.65 2.56 23.12 1.05
Debt to NOPAT
8.91 -39.42 -412.05 -62.93 11.31 6.81 3.03 546.16 42.48 -7.83 2.82
Net Debt to NOPAT
5.14 -20.70 -142.50 -7.18 1.45 1.07 -1.12 -186.96 -7.03 -1.81 0.24
Long-Term Debt to NOPAT
8.68 -39.36 -361.52 -62.87 9.58 6.81 2.78 538.49 42.48 -6.22 2.52
Altman Z-Score
1.04 0.99 1.50 1.88 1.73 1.62 2.29 2.11 1.58 0.80 1.66
Noncontrolling Interest Sharing Ratio
22.04% 21.03% 15.65% 9.14% 8.66% 5.92% 4.03% 1.55% 0.04% 0.73% 0.61%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.47 3.52 2.67 3.62 2.95 2.63 2.52 2.90 2.23 1.25 1.63
Quick Ratio
1.34 1.83 1.80 2.55 2.07 1.20 1.86 2.04 1.52 0.63 0.62
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,398 1,802 1,493 1,422 303 -9,746 3,521 1,719 1,556 -14,223 6,073
Operating Cash Flow to CapEx
379.42% 193.59% 247.86% 246.69% 181.25% 200.00% 3,343.84% 272.72% 152.25% 103.64% 223.89%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.28 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.62 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.89 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.28 0.24 0.29 0.35 0.35 0.32 0.28 0.30 0.30 0.25 0.33
Accounts Receivable Turnover
14.24 17.61 23.94 25.44 29.54 31.07 27.97 31.10 23.20 16.59 20.87
Inventory Turnover
2.71 2.64 2.98 3.24 3.05 3.30 2.77 3.04 3.65 3.05 3.71
Fixed Asset Turnover
0.49 0.45 0.52 0.59 0.59 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
8.87 9.93 12.77 12.76 12.07 12.34 9.72 10.75 11.24 8.41 9.94
Days Sales Outstanding (DSO)
25.64 20.72 15.24 14.34 12.35 11.75 13.05 11.74 15.73 22.00 17.49
Days Inventory Outstanding (DIO)
134.49 138.18 122.55 112.60 119.59 110.76 131.62 120.11 99.88 119.73 98.26
Days Payable Outstanding (DPO)
41.17 36.78 28.58 28.61 30.23 29.58 37.56 33.95 32.48 43.40 36.71
Cash Conversion Cycle (CCC)
118.96 122.12 109.22 98.33 101.71 92.93 107.10 97.90 83.14 98.34 79.04
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
16,925 14,974 13,470 11,983 12,057 22,792 21,448 19,740 18,326 31,359 28,431
Invested Capital Turnover
0.40 0.38 0.47 0.58 0.60 0.56 0.52 0.59 0.63 0.48 0.62
Increase / (Decrease) in Invested Capital
-652 -1,951 -1,504 -1,487 74 10,735 -1,344 -1,708 -1,414 13,033 -2,928
Enterprise Value (EV)
14,218 13,700 17,391 17,766 16,850 32,778 40,677 42,748 34,311 34,428 43,308
Market Capitalization
7,567 7,679 14,642 16,318 15,295 30,726 42,237 45,030 35,131 32,096 42,373
Book Value per Share
$20.60 $21.45 $20.20 $19.75 $19.72 $26.13 $28.64 $27.62 $24.38 $36.52 $26.29
Tangible Book Value per Share
$20.60 $21.45 $20.20 $19.75 $19.61 $22.87 $25.19 $24.14 $21.90 $32.75 $23.95
Total Capital
19,735 20,155 16,489 15,584 15,773 29,151 30,475 28,057 25,569 38,527 38,974
Total Debt
6,646 5,863 4,615 4,065 4,261 6,734 6,596 6,196 6,036 9,322 8,865
Total Long-Term Debt
6,480 5,854 4,049 4,061 3,608 6,734 6,045 6,109 6,036 7,399 7,941
Net Debt
3,836 3,079 1,596 464 545 1,055 -2,431 -2,121 -999 2,154 754
Capital Expenditures (CapEx)
379 1,108 1,124 861 1,008 1,433 146 1,569 2,115 2,666 2,842
Debt-free, Cash-free Net Working Capital (DFCFNWC)
931 1,194 681 351 698 1,407 -143 55 -168 412 2,016
Debt-free Net Working Capital (DFNWC)
3,407 3,576 3,493 3,672 4,143 3,887 5,687 5,129 3,589 3,437 5,656
Net Working Capital (NWC)
3,241 3,567 2,927 3,668 3,490 3,887 5,136 5,042 3,589 1,514 4,732
Net Nonoperating Expense (NNE)
417 -453 932 44 -3.20 -1,895 -614 -222 511 1,277 -236
Net Nonoperating Obligations (NNO)
3,836 682 1,596 464 545 375 -2,431 -2,121 -1,207 2,154 -1,678
Total Depreciation and Amortization (D&A)
1,088 1,102 1,213 1,261 1,215 1,960 2,300 2,323 2,185 2,108 2,576
Debt-free, Cash-free Net Working Capital to Revenue
13.65% 19.62% 10.19% 4.76% 9.62% 14.45% -1.24% 0.45% -1.41% 3.49% 10.79%
Debt-free Net Working Capital to Revenue
49.96% 58.77% 52.29% 49.76% 57.12% 39.91% 49.47% 41.97% 30.12% 29.10% 30.28%
Net Working Capital to Revenue
47.53% 58.62% 43.82% 49.71% 48.12% 39.91% 44.67% 41.25% 30.12% 12.82% 25.33%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.02 $0.43 ($1.18) ($0.18) $0.64 $3.82 $3.52 $1.46 ($0.54) ($2.97) $2.92
Adjusted Weighted Average Basic Shares Outstanding
498.86M 529.16M 531.15M 533.47M 532.67M 807.58M 800.31M 799M 794M 841M 1.15B
Adjusted Diluted Earnings per Share
$1.02 $0.43 ($1.18) ($0.18) $0.64 $3.81 $3.51 $1.46 ($0.54) ($2.97) $2.92
Adjusted Weighted Average Diluted Shares Outstanding
498.86M 529.16M 531.15M 533.47M 532.67M 807.58M 800.31M 801M 795M 841M 1.15B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
498.86M 529.16M 531.15M 533.47M 532.67M 807.58M 800.31M 792.50M 793.79M 1.15B 1.13B
Normalized Net Operating Profit after Tax (NOPAT)
766 359 732 891 811 989 2,216 897 1,066 134 3,199
Normalized NOPAT Margin
11.23% 5.90% 10.95% 12.08% 11.19% 10.16% 19.27% 7.34% 8.95% 1.13% 17.13%
Pre Tax Income Margin
12.04% 4.85% -3.29% 14.53% 10.18% 37.92% 27.34% 9.07% -0.43% -17.19% 24.50%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.04 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.68 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -5.68 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
38.60% 20.72% -24.92% -330.28% 121.32% 37.27% 36.94% 839.91% -524.93% -63.44% 38.63%
Augmented Payout Ratio
38.60% 20.72% -24.92% -330.28% 147.11% 53.88% 55.61% 1,065.24% -524.93% -63.44% 75.48%

Quarterly Metrics And Ratios for Newmont

This table displays calculated financial ratios and metrics derived from Newmont's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-5.60% -11.38% -12.26% -5.35% 23.66% 50.17% 64.07% 84.72% 42.84% 24.53% 20.79%
EBITDA Growth
-483.33% -13.90% -18.46% -11.53% -208.30% 10.33% 108.50% 133.68% 221.20% 167.49% 118.44%
EBIT Growth
-201.59% -12.46% -24.95% -20.23% -127.14% -13.74% 226.36% 308.93% 171.07% 389.44% 179.46%
NOPAT Growth
-128.59% -42.01% -66.32% -18.17% -96.30% -48.60% 407.03% 432.21% 165.61% 957.34% 135.24%
Net Income Growth
-90.84% -22.60% -61.25% -25.91% -115.91% -50.69% 452.90% 466.87% 145.14% 962.57% 142.12%
EPS Growth
-3,620.00% -21.43% -61.22% -25.93% -104.30% -65.91% 289.47% 300.00% 132.37% 1,020.00% 150.00%
Operating Cash Flow Growth
-22.25% -30.69% -36.43% 112.05% -39.01% 61.33% 115.38% 64.31% 307.63% 161.73% 66.95%
Free Cash Flow Firm Growth
-67.53% -4.23% -34.79% 189.84% -3,737.96% -713.48% -784.81% -630.63% 128.12% 111.34% 122.17%
Invested Capital Growth
-7.16% -5.96% -5.43% -7.42% 71.12% 49.67% 49.83% 51.72% -9.34% 2.18% 0.28%
Revenue Q/Q Growth
21.49% -16.28% 0.15% -7.08% 58.72% 1.67% 9.42% 4.61% 22.74% -11.36% 6.13%
EBITDA Q/Q Growth
-188.36% 240.32% -21.60% -8.98% -407.89% 150.21% 48.17% 2.01% 59.68% 10.83% 21.00%
EBIT Q/Q Growth
-478.92% 145.41% -42.22% -19.77% -1,178.93% 117.25% 118.62% 0.53% 87.51% 18.77% 24.82%
NOPAT Q/Q Growth
-602.55% 130.49% -45.28% -2.41% -1,305.49% 107.99% 439.74% 2.44% 48.61% 28.68% 20.08%
Net Income Q/Q Growth
-762.73% 124.90% -57.30% 5.16% -2,031.29% 105.69% 378.77% 7.82% 53.79% 33.85% 9.10%
EPS Q/Q Growth
-788.89% 123.66% -56.82% 5.26% -2,000.00% 103.95% 393.33% 8.11% 53.75% 36.59% 10.12%
Operating Cash Flow Q/Q Growth
113.53% -52.38% 37.84% 51.28% -38.58% 25.97% 84.02% 15.41% 52.37% -19.12% 17.38%
Free Cash Flow Firm Q/Q Growth
-28.83% 264.16% -16.07% 33.25% -993.29% 36.72% 6.31% -3.25% 147.34% -75.25% 83.26%
Invested Capital Q/Q Growth
-10.26% 2.92% 0.84% -0.60% 65.87% -8.69% 0.95% 0.66% -0.88% 1.46% -0.93%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
44.38% 44.68% 42.49% 45.01% 41.80% 47.65% 51.02% 49.84% 57.70% 57.96% 62.37%
EBITDA Margin
-23.72% 39.75% 31.12% 30.49% -59.14% 29.21% 39.55% 38.57% 50.18% 62.73% 71.53%
Operating Margin
-44.72% 18.85% 13.64% 9.55% -70.99% 9.94% 23.60% 24.50% 34.68% 44.89% 57.70%
EBIT Margin
-41.56% 22.55% 13.01% 11.23% -76.35% 12.95% 25.87% 24.86% 37.99% 50.90% 59.86%
Profit (Net Income) Margin
-45.56% 13.55% 5.78% 6.54% -79.56% 4.45% 19.47% 20.07% 25.14% 37.96% 39.03%
Tax Burden Percent
105.42% 67.35% 51.67% 70.26% 101.48% 41.82% 82.72% 87.25% 69.18% 76.97% 66.55%
Interest Burden Percent
103.99% 89.24% 85.96% 82.86% 102.68% 82.15% 90.96% 92.49% 95.67% 96.90% 97.96%
Effective Tax Rate
0.00% 39.52% 54.33% 31.47% 0.00% 60.75% 18.44% 23.04% 34.18% 26.18% 35.02%
Return on Invested Capital (ROIC)
-19.60% 6.78% 3.56% 3.68% -23.63% 2.18% 12.05% 13.46% 14.26% 22.84% 27.04%
ROIC Less NNEP Spread (ROIC-NNEP)
7.83% 1.71% 4.86% 3.70% -273.19% -0.67% 10.75% 6.32% 69.25% 8.73% 23.63%
Return on Net Nonoperating Assets (RNNOA)
-0.63% -0.09% -0.22% -0.12% -5.31% 0.02% -0.32% -0.20% 0.56% -0.50% -1.82%
Return on Equity (ROE)
-20.23% 6.69% 3.34% 3.56% -28.94% 2.20% 11.73% 13.26% 14.82% 22.34% 25.22%
Cash Return on Invested Capital (CROIC)
8.18% 5.82% 4.64% 6.56% -57.25% -45.15% -43.22% -41.80% 20.32% 14.16% 20.08%
Operating Return on Assets (OROA)
-12.53% 6.66% 3.74% 3.22% -19.19% 3.64% 8.21% 8.96% 12.69% 18.06% 22.23%
Return on Assets (ROA)
-13.74% 4.01% 1.66% 1.87% -20.00% 1.25% 6.17% 7.23% 8.40% 13.47% 14.49%
Return on Common Equity (ROCE)
-20.22% 6.63% 3.31% 3.53% -28.72% 2.19% 11.64% 13.16% 14.73% 22.21% 25.07%
Return on Equity Simple (ROE_SIMPLE)
0.00% -2.45% -3.75% -4.07% 0.00% -9.18% -6.63% -4.00% 0.00% 16.33% 19.69%
Net Operating Profit after Tax (NOPAT)
-1,002 305 167 163 -1,966 157 847 868 1,290 1,660 1,994
NOPAT Margin
-31.30% 11.40% 6.23% 6.54% -49.69% 3.90% 19.25% 18.85% 22.83% 33.14% 37.49%
Net Nonoperating Expense Percent (NNEP)
-27.42% 5.07% -1.29% -0.02% 249.57% 2.85% 1.31% 7.14% -54.99% 14.10% 3.41%
Return On Investment Capital (ROIC_SIMPLE)
-3.92% - - - -5.10% - - - 3.31% 4.22% 5.01%
Cost of Revenue to Revenue
55.63% 55.32% 57.51% 54.99% 58.20% 52.35% 48.98% 50.16% 42.30% 42.04% 37.63%
SG&A Expenses to Revenue
3.59% 3.06% 4.17% 4.29% 13.01% 4.33% 3.61% 3.65% 2.34% 3.05% 2.69%
R&D to Revenue
1.88% 1.31% 1.64% 2.13% 1.72% 1.32% 1.11% 1.02% 0.85% 0.86% 0.75%
Operating Expenses to Revenue
89.09% 25.83% 28.85% 35.46% 112.79% 37.71% 27.42% 25.34% 23.02% 13.07% 4.66%
Earnings before Interest and Taxes (EBIT)
-1,330 604 349 280 -3,021 521 1,139 1,145 2,147 2,550 3,183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-759 1,065 835 760 -2,340 1,175 1,741 1,776 2,836 3,143 3,803
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.82 1.92 1.70 1.50 1.11 1.42 1.64 2.06 1.42 1.74 2.02
Price to Tangible Book Value (P/TBV)
2.02 2.14 1.90 1.67 1.23 1.57 1.82 2.27 1.55 1.90 2.20
Price to Revenue (P/Rev)
2.95 3.22 2.93 2.58 2.72 3.12 3.25 3.61 2.27 2.77 3.15
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.66 10.73 10.33
Dividend Yield
4.97% 4.37% 4.61% 4.87% 5.32% 4.07% 3.10% 2.15% 2.69% 2.07% 2.15%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.90% 9.32% 9.68%
Enterprise Value to Invested Capital (EV/IC)
1.87 1.95 1.71 1.50 1.10 1.56 1.77 2.21 1.52 1.83 2.15
Enterprise Value to Revenue (EV/Rev)
2.88 3.17 2.91 2.57 2.91 3.35 3.39 3.73 2.32 2.69 2.98
Enterprise Value to EBITDA (EV/EBITDA)
14.53 16.77 16.28 14.92 107.59 102.60 37.70 26.91 5.75 5.57 5.31
Enterprise Value to EBIT (EV/EBIT)
194.95 408.00 0.00 0.00 0.00 0.00 0.00 0.00 8.75 7.58 6.80
Enterprise Value to NOPAT (EV/NOPAT)
241.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.77 11.36 10.57
Enterprise Value to Operating Cash Flow (EV/OCF)
10.66 12.21 12.39 8.99 12.46 14.43 13.17 14.17 6.81 6.94 7.16
Enterprise Value to Free Cash Flow (EV/FCFF)
22.05 32.43 35.88 21.98 0.00 0.00 0.00 0.00 7.13 13.09 10.71
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.31 0.31 0.31 0.31 0.32 0.32 0.29 0.30 0.29 0.25 0.23
Long-Term Debt to Equity
0.31 0.31 0.31 0.31 0.25 0.32 0.29 0.30 0.26 0.25 0.23
Financial Leverage
-0.08 -0.06 -0.05 -0.03 0.02 -0.03 -0.03 -0.03 0.01 -0.06 -0.08
Leverage Ratio
1.91 1.90 1.90 1.90 1.93 1.93 1.92 1.92 1.89 1.83 1.79
Compound Leverage Factor
1.99 1.70 1.63 1.57 1.98 1.58 1.74 1.77 1.80 1.78 1.76
Debt to Total Capital
23.61% 23.54% 23.65% 23.73% 24.20% 24.37% 22.72% 23.11% 22.75% 20.04% 18.84%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 4.99% 0.00% 0.00% 0.00% 2.37% 0.00% 0.00%
Long-Term Debt to Total Capital
23.61% 23.54% 23.65% 23.73% 19.20% 24.37% 22.72% 23.11% 20.38% 20.04% 18.84%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.70% 0.71% 0.75% 0.74% 0.46% 0.48% 0.48% 0.47% 0.46% 0.47% 0.44%
Common Equity to Total Capital
75.69% 75.74% 75.60% 75.53% 75.34% 75.15% 76.80% 76.41% 76.79% 79.50% 80.72%
Debt to EBITDA
2.56 2.75 3.01 3.15 29.13 21.79 6.51 3.82 1.18 0.83 0.65
Net Debt to EBITDA
-0.42 -0.32 -0.20 -0.19 6.73 6.68 1.42 0.76 0.10 -0.18 -0.31
Long-Term Debt to EBITDA
2.56 2.75 3.01 3.15 23.12 21.79 6.51 3.82 1.05 0.83 0.65
Debt to NOPAT
42.48 -94.55 -32.43 -26.59 -7.83 -7.42 -10.97 -53.05 2.82 1.69 1.29
Net Debt to NOPAT
-7.03 10.94 2.13 1.57 -1.81 -2.27 -2.40 -10.50 0.24 -0.36 -0.62
Long-Term Debt to NOPAT
42.48 -94.55 -32.43 -26.59 -6.22 -7.42 -10.97 -53.05 2.52 1.69 1.29
Altman Z-Score
1.45 1.69 1.51 1.35 0.72 1.27 1.52 1.85 1.49 1.98 2.43
Noncontrolling Interest Sharing Ratio
0.04% 0.88% 0.90% 0.90% 0.73% 0.75% 0.76% 0.75% 0.61% 0.61% 0.58%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.23 2.38 2.28 2.12 1.25 2.15 2.11 1.96 1.63 1.98 2.23
Quick Ratio
1.52 1.40 1.27 1.17 0.63 0.57 0.63 0.63 0.62 1.03 1.56
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
412 1,501 1,260 1,679 -14,999 -9,211 -8,630 -8,910 4,218 1,044 1,914
Operating Cash Flow to CapEx
156.35% 91.44% 107.63% 166.06% 66.96% 91.29% 178.50% 187.91% 286.97% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.30 0.30 0.29 0.29 0.25 0.28 0.32 0.36 0.33 0.35 0.37
Accounts Receivable Turnover
23.20 30.41 40.79 60.25 16.59 23.29 26.10 32.29 20.87 23.57 25.86
Inventory Turnover
3.65 3.50 3.49 3.38 3.05 3.57 3.86 4.30 3.71 4.06 3.99
Fixed Asset Turnover
0.00 0.48 0.46 0.45 0.00 0.46 0.51 0.58 0.00 0.59 0.61
Accounts Payable Turnover
11.24 11.44 11.06 10.12 8.41 10.88 12.72 12.47 9.94 12.20 12.36
Days Sales Outstanding (DSO)
15.73 12.00 8.95 6.06 22.00 15.68 13.99 11.30 17.49 15.49 14.11
Days Inventory Outstanding (DIO)
99.88 104.43 104.70 107.86 119.73 102.23 94.68 84.95 98.26 89.90 91.48
Days Payable Outstanding (DPO)
32.48 31.91 32.99 36.08 43.40 33.54 28.70 29.26 36.71 29.91 29.53
Cash Conversion Cycle (CCC)
83.14 84.53 80.66 77.84 98.34 84.36 79.96 66.99 79.04 75.47 76.07
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
18,326 18,862 19,020 18,906 31,359 28,230 28,497 28,684 28,431 28,846 28,577
Invested Capital Turnover
0.63 0.59 0.57 0.56 0.48 0.56 0.63 0.71 0.62 0.69 0.72
Increase / (Decrease) in Invested Capital
-1,414 -1,196 -1,093 -1,516 13,033 9,368 9,477 9,778 -2,928 616 80
Enterprise Value (EV)
34,311 36,720 32,561 28,369 34,428 44,118 50,365 63,292 43,308 52,893 61,405
Market Capitalization
35,131 37,235 32,766 28,537 32,096 41,061 48,282 61,330 42,373 54,405 64,843
Book Value per Share
$24.38 $24.41 $24.19 $24.00 $36.52 $25.07 $25.48 $25.89 $26.29 $27.73 $28.85
Tangible Book Value per Share
$21.90 $21.93 $21.71 $21.52 $32.75 $22.64 $23.06 $23.52 $23.95 $25.37 $26.46
Total Capital
25,569 25,582 25,430 25,253 38,527 38,444 38,255 38,883 38,974 39,308 39,782
Total Debt
6,036 6,023 6,015 5,993 9,322 9,369 8,692 8,987 8,865 7,877 7,495
Total Long-Term Debt
6,036 6,023 6,015 5,993 7,399 9,369 8,692 8,987 7,941 7,877 7,495
Net Debt
-999 -697 -395 -354 2,154 2,872 1,899 1,778 754 -1,695 -3,613
Capital Expenditures (CapEx)
646 526 616 604 920 850 800 877 875 -858 -317
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-168 303 203 -67 412 3,965 3,686 3,110 2,016 598 -924
Debt-free Net Working Capital (DFNWC)
3,589 3,807 3,441 3,147 3,437 6,324 6,338 6,169 5,656 5,314 5,729
Net Working Capital (NWC)
3,589 3,807 3,441 3,147 1,514 6,324 6,338 6,169 4,732 5,314 5,729
Net Nonoperating Expense (NNE)
456 -58 12 0.11 1,182 -22 -9.55 -56 -131 -242 -81
Net Nonoperating Obligations (NNO)
-1,207 -697 -395 -354 2,154 -845 -1,066 -1,212 -1,678 -2,585 -3,710
Total Depreciation and Amortization (D&A)
571 461 486 480 681 654 602 631 689 593 620
Debt-free, Cash-free Net Working Capital to Revenue
-1.41% 2.62% 1.81% -0.61% 3.49% 30.14% 24.78% 18.31% 10.79% 3.04% -4.49%
Debt-free Net Working Capital to Revenue
30.12% 32.90% 30.73% 28.47% 29.10% 48.07% 42.61% 36.32% 30.28% 27.02% 27.83%
Net Working Capital to Revenue
30.12% 32.90% 30.73% 28.47% 12.82% 48.07% 42.61% 36.32% 25.33% 27.02% 27.83%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.86) $0.44 $0.19 $0.20 ($3.80) $0.15 $0.74 $0.80 $1.23 $1.68 $1.86
Adjusted Weighted Average Basic Shares Outstanding
794M 794M 795M 795M 841M 1.15B 1.15B 1.15B 1.15B 1.13B 1.11B
Adjusted Diluted Earnings per Share
($1.86) $0.44 $0.19 $0.20 ($3.80) $0.15 $0.74 $0.80 $1.23 $1.68 $1.85
Adjusted Weighted Average Diluted Shares Outstanding
795M 795M 795M 796M 841M 1.15B 1.16B 1.15B 1.15B 1.13B 1.11B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
793.79M 794.71M 794.73M 794.80M 1.15B 1.15B 1.15B 1.14B 1.13B 1.11B 1.10B
Normalized Net Operating Profit after Tax (NOPAT)
-1,002 305 256 163 -1,966 280 847 868 1,290 1,456 1,994
Normalized NOPAT Margin
-31.30% 11.40% 9.55% 6.54% -49.69% 6.96% 19.25% 18.85% 22.83% 29.07% 37.49%
Pre Tax Income Margin
-43.22% 20.12% 11.18% 9.31% -78.39% 10.64% 23.53% 23.00% 36.34% 49.32% 58.64%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-524.93% -377.68% -230.97% -199.23% -63.44% -58.17% -77.83% -124.58% 38.63% 25.53% 20.77%
Augmented Payout Ratio
-524.93% -377.68% -230.97% -199.23% -63.44% -58.17% -83.17% -162.29% 75.48% 56.76% 60.33%

Key Financial Trends

Newmont (NYSE: NEM) Financial Highlights and Trends (Q2 2022 – Q2 2025)

Over the past three years, Newmont has shown a recovery and growth trajectory after dealing with a challenging Q4 2022. Here is a summary of key financial trends and data points extracted from Newmont’s quarterly cash flow statements, income statements, and balance sheets.

  • Net Income has demonstrated a strong rebound from a net loss of approximately -$3.15 billion in Q4 2023 to positive net income of $2.075 billion in Q2 2025, reflecting improved profitability.
  • Operating Revenue steadily increased from about $2.68 billion in Q2 2023 to $5.32 billion in Q2 2025, indicating growing sales and operational scale.
  • Total Gross Profit improved significantly, reaching approximately $3.32 billion in Q2 2025, compared to prior levels near $1.14 billion in Q2 2023.
  • Depreciation expense has been relatively stable around $600 million per quarter, consistent with strong asset base investment, which supports ongoing operations.
  • Cash and cash equivalents have grown from approximately $2.83 billion in Q2 2023 to $6.19 billion by Q2 2025, improving liquidity and financial flexibility.
  • Net cash from operating activities improved significantly, from $656 million in Q2 2023 to $2.38 billion in Q2 2025, indicating strong cash generation from core operations.
  • Capital expenditures (Purchase of Property, Plant, & Equipment) remain substantial, reaching $674 million in Q2 2025, which pressures free cash flow but signals ongoing investments for future growth.
  • Repurchase of Common Equity has increased, with $1.01 billion spent in Q2 2025, which, while returning capital to shareholders, reduces cash reserves.
  • Long-term debt remains elevated around $7.1 billion as of Q2 2025, down slightly from approximately $8.7 billion in Q1 2024, but still significant, affecting leverage ratios.
  • Dividends payments are steady at $0.25 per share on a quarterly basis, demonstrating a commitment to shareholder returns without excess strain on cash flows.

Summary: Newmont has successfully turned around its financial performance since Q4 2022 losses, with strong revenue and net income growth through mid-2025. Increased operating cash flow and strong gross profit margin improvements underpin this recovery. Ongoing investments in property, plant, and equipment, along with substantial equity repurchases, indicate management confidence but also represent cash outflows to monitor. The company maintains solid liquidity and continues to pay consistent dividends, supporting shareholder value. However, elevated debt levels warrant attention from investors regarding leverage risk.

08/22/25 06:42 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Newmont's Financials

When does Newmont's fiscal year end?

According to the most recent income statement we have on file, Newmont's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Newmont's net income changed over the last 10 years?

Newmont's net income appears to be on an upward trend, with a most recent value of $3.38 billion in 2024, rising from $329 million in 2014. The previous period was -$2.47 billion in 2023. View Newmont's forecast to see where analysts expect Newmont to go next.

What is Newmont's operating income?
Newmont's total operating income in 2024 was $4.53 billion, based on the following breakdown:
  • Total Gross Profit: $9.72 billion
  • Total Operating Expenses: $5.19 billion
How has Newmont's revenue changed over the last 10 years?

Over the last 10 years, Newmont's total revenue changed from $6.82 billion in 2014 to $18.68 billion in 2024, a change of 174.0%.

How much debt does Newmont have?

Newmont's total liabilities were at $26.24 billion at the end of 2024, a 0.2% decrease from 2023, and a 121.9% increase since 2014.

How much cash does Newmont have?

In the past 10 years, Newmont's cash and equivalents has ranged from $2.24 billion in 2019 to $5.54 billion in 2020, and is currently $3.62 billion as of their latest financial filing in 2024.

How has Newmont's book value per share changed over the last 10 years?

Over the last 10 years, Newmont's book value per share changed from 20.60 in 2014 to 26.29 in 2024, a change of 27.6%.



This page (NYSE:NEM) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners